This other source you link here is an actual article but doesn't say what you claim it does.It doesn't?
I said that the Sars-Cov-2 spike protein has prions. The same prions which cause the mad cow disease.
http://hmi-us.com/publications/sars-cov-2-prion-like-domains-in-spike-proteins-enable-higher-affinity-to-ace2.htmlIn this in silico study, using the PLAAC algorithm, we identified the presence of prion-like domains in the SARS-CoV-2 spike protein. Compared with other viruses, a striking difference was observed in the distribution of prion-like domains in the spike protein, since SARS-CoV-2 was the only coronavirus with a prion-like domain found in the receptor-binding domain of the S1 region of the spike protein.
You don't like Dr. Classen? Fine.
The spike protein encoded by the vaccine binds angiotensin
converting enzyme 2 (ACE2), an enzyme which contains zinc
molecules [8]. The binding of spike protein to ACE2 has the
potential to release the zinc molecule, an ion that causes TDP-43
to assume its pathologic prion transformation [9].
8. Shang J, Ye G, Shi K, et al. Structural basis of receptor
recognition by SARS-CoV-2. Nature. 2020; 581: 221-225.
9. Garnier C, Devred F, Byrne D, et al. Zinc binding to RNA
recognition motif of TDP-43 induces the formation of amyloidlike aggregates. Sci Rep. 2017; 7: 6812.
Additional support that COVID-19 vaccines could potentially induce prion disease.
Authors [18] found prion related sequences in the COVID-19 spike
protein which were not found in related coronaviruses. Others [19]
have reported a case of prion disease, Creutzfeldt-Jakob disease,
initially occurring in a man with COVID-19.
18. Tetz G, Tetz V. SARS-CoV-2 prion-like domains in spike
proteins enable higher affinity to ACE2. Preprint. 2020.
19. Young MJ, O’Hare M, Matiello M, et al. Creutzfeldt-Jakob
disease in a man with COVID-19: SARS-CoV-2-accelerated
neuro degeneration? Brain, Behavior, and Immunity. 2020; 89:
601-603.
Nowhere does it say people are dying of mad-covid-vaccine disease.19. Young MJ, O’Hare M, Matiello M, et al. Creutzfeldt-Jakob
disease in a man with COVID-19: SARS-CoV-2-accelerated
neuro degeneration? Brain, Behavior, and Immunity. 2020; 89:
601-603.
https://www.cnbc.com/2021/04/07/1-in-3-covid-survivors-suffer-neurological-or-mental-disorders-study.htmlI will rephrase: what kind of data would you expect from the tests in case there was a satisfactory vaccine?I already answered your question. A satisfactory vaccine, like the BCG, will stop transmission and also offer 100% immunity.
Here is the real world data which you are avoiding:
ARR
162/21726 - 8/21720 = 0.007 = 0.7%
This is the figure which was never published by Pfizer.
NNTV = 1/ARR = 100/0.7 = 142.8
https://www.mdpi.com/1648-9144/57/3/199/htmThis is what you have to deal with: only one person in 142 will develop antibodies for some six weeks at most, the rest, for a total of 141, will receive nothing.
Do you understand that is figure, 0.7% is the actual ARR for the Pfizer study? Are you able to comprehend this much? Then, the NNTV is 142.